MediciNova, Avigen Merge To Boost Ibudilast Efforts
MediciNova Inc. announced Friday it had entered into a merger deal in which it will buy Avigen Inc., allowing the biopharmaceutical companies to combine their neurological clinical development efforts regarding anti-inflammatory...To view the full article, register now.
Already a subscriber? Click here to view full article